<unk>  is a form of treatment that uses<unk>  oligonucleotides (ASOs) to target messenger RNA (mRNA). ASOs are capable of altering mRNA expression through a variety of mechanisms, including ribonuclease H mediated decay of the pre-mRNA, direct steric blockage, and exon content modulation through splicing site binding on pre-mRNA. Several ASOs have been approved in the United States, the European Union, and elsewhere.
Antisense therapy
Differentiation therapy
Aversion therapy
Destination therapy
Cell therapy
Cytoluminescent therapy
Dark therapy
Epigenetic therapy